CLEAR Study: Clinical Experience Acquired With Raptiva Study

Clinical trial NCT00256139 · COMPLETED

Trial details

NCT number: NCT00256139
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Moderate to Severe Psoriasis

Start date: 2003-03-01
Primary completion: 2004-10-01
Enrollment: 793

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.